Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

regorafenib

  • You have access
    Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience
    CARLO SIGNORELLI, DONATELLO GEMMA, ROBERTA GRANDE, SALVATORE DE MARCO, ROSA SALTARELLI, MARIA GRAZIA MORANDI, GIAN PAOLO SPINELLI, FEDERICA ZORATTO, ISABELLA SPERDUTI, MARIO GIOVANNI CHILELLI, ANNA CERIBELLI and ENZO MARIA RUGGERI
    Anticancer Research May 2021, 41 (5) 2553-2561; DOI: https://doi.org/10.21873/anticanres.15033
  • You have access
    Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
    YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO and YASUHIRO SHIMADA
    Anticancer Research April 2021, 41 (4) 2203-2207; DOI: https://doi.org/10.21873/anticanres.14996
  • You have access
    Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib
    MARIOS PAPADIMITRIOU and CHRISTOS A. PAPADIMITRIOU
    Anticancer Research February 2021, 41 (2) 567-582; DOI: https://doi.org/10.21873/anticanres.14809
  • You have access
    A Systematic Review and Meta-analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer
    JOEY MERCIER and IOANNIS A. VOUTSADAKIS
    Anticancer Research November 2017, 37 (11) 5925-5934;
  • You have access
    Regorafenib Induces Apoptosis and Inhibits Metastatic Potential of Human Bladder Carcinoma Cells
    FEI-TING HSU, CHO-CHIN SUN, CHIA-HSING WU, YEN-JU LEE, CHIH-HUNG CHIANG and WEI-SHU WANG
    Anticancer Research September 2017, 37 (9) 4919-4926;
  • You have access
    Efficacy and Safety of Regorafenib or TAS-102 in Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies
    TOSHINORI SUEDA, DAISUKE SAKAI, TOSHIHIRO KUDO, TAKASHI SUGIURA, HIDEKAZU TAKAHASHI, NAOTSUGU HARAGUCHI, JUNICHI NISHIMURA, TAISHI HATA, TARO HAYASHI, TSUNEKAZU MIZUSHIMA, YUICHIRO DOKI, MASAKI MORI and TAROH SATOH
    Anticancer Research August 2016, 36 (8) 4299-4306;
  • You have access
    Efficacy and Safety of TAS-102 in Clinical Practice of Salvage Chemotherapy for Metastatic Colorectal Cancer
    SHUJI ARITA, TSUYOSHI SHIRAKAWA, YUZO MATSUSHITA, HOZUMI KUMAGAI SHIMOKAWA, GEN HIRANO, AKITAKA MAKIYAMA, YOSHIHIRO SHIBATA, SHINGO TAMURA, TAITO ESAKI, KENJI MITSUGI, HIROSHI ARIYAMA, HITOSHI KUSABA, KOICHI AKASHI and EISHI BABA
    Anticancer Research April 2016, 36 (4) 1959-1966;
  • You have access
    Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats
    KAZUO HOTTA, JUN UEYAMA, YASUAKI TATSUMI, IKUTO TSUKIYAMA, YUKA SUGIURA, HIROKO SAITO, KATSUHIKO MATSUURA and TAKAAKI HASEGAWA
    Anticancer Research September 2015, 35 (9) 4681-4689;
  • You have access
    Investigation of Regorafenib-induced Hypothyroidism in Patients with Metastatic Colorectal Cancer
    KAZUO SUGITA, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, YUTARO MAE, WATARU TOYA, AKANE HAGINO, KENICHI SUZUKI, MITSUKUNI SUENAGA, NOBUYUKI MIZUNUMA, TOSHIHARU YAMAGUCHI and TOSHIHIRO HAMA
    Anticancer Research July 2015, 35 (7) 4059-4062;
  • You have access
    Reduced Dose of Salvage-line Regorafenib Monotherapy for Metastatic Colorectal Cancer in Japan
    GEN HIRANO, AKITAKA MAKIYAMA, CHINATSU MAKIYAMA, TAITO ESAKI, HISANOBU ODA, KEITA UCHINO, MASATO KOMODA, RISA TANAKA, YUZO MATSUSHITA, KENJI MITSUGI, YOSHIHIRO SHIBATA, HOZUMI KUMAGAI, SHUJI ARITA, HIROSHI ARIYAMA, HITOSHI KUSABA, KOICHI AKASHI and EISHI BABA
    Anticancer Research January 2015, 35 (1) 371-377;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire